NCT01846507View on ClinicalTrials.gov

Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Heavy Menstrual Bleeding
Interventions
DRUG

Tranexamic Acid

Subjects will be instructed to take 2 tablets (1300) mg of Lysteda three times daily (3900 mg/daily) for five days during monthly menstruation.

Trial Locations (5)

43205

Nationwide Children's Hospital, Columbus

44106

Rainbow Babies & Children's Hospital, Cleveland

44302

Akron Children's Hospital, Akron

46202

Riley Hospital for Children at IU Health, Indianapolis

64108

Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT01846507 - Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding | Biotech Hunter | Biotech Hunter